Cargando…
Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?
Nitric oxide (NO) is an important regulator of vascular tone, and is also an antithrombotic, anti-inflammatory, antiproliferative, and antiatherogenic factor. Endothelial function is altered in patients with coronary artery disease, stroke, and peripheral artery disease, and endothelial dysfunction...
Autores principales: | Rubio-Guerra, Alberto Francisco, Vargas-Robles, Hilda, Ramos-Brizuela, Luz Maria, Escalante-Acosta, Bruno Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172060/ https://www.ncbi.nlm.nih.gov/pubmed/21949628 http://dx.doi.org/10.2147/IBPC.S7479 |
Ejemplares similares
-
Correlation between biopterin levels and intimal-media thickness in type-2 diabetic hypertensive patients
por: Rubio-Guerra, Alberto Francisco, et al.
Publicado: (2014) -
Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
por: Rubio-Guerra, Alberto F, et al.
Publicado: (2009) -
Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
por: Hong, Won Ki, et al.
Publicado: (2014) -
Central Tetrahydrobiopterin Concentration in Neurodevelopmental Disorders
por: Frye, Richard E.
Publicado: (2010) -
Modulation of Radiation Response by the Tetrahydrobiopterin Pathway
por: Pathak, Rupak, et al.
Publicado: (2015)